AdoRx Therapeutics Company
AdoRx Therapeutics is pursuing the discovery of new therapeutics for cancer based on modulation of the adenosine pathway.
Industry:
PharmTech
Technology:
Small Molecules
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Headquarters:
Edinburgh, Edinburgh, City of, United Kingdom
Employee Number:
1-10
Founded Date:
2017